EKF Diagnostics Holdings Plc (EKF)-Medical Equipment-Deals and Alliances Profile

EKF Diagnostics Holdings Plc (EKF)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME211150D
  • |
  • Pages: 50
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

EKF Diagnostics Holdings Plc (EKF Diagnostics) is a medical device company which designs, develops, manufactures, and commercializes chemical reagents, and analyzers for the measurement of glucose, lactate, hematocrit, hemoglobin, and glycated hemoglobin. The company's product portfolio comprises HbA1c analyzers, hemoglobin analyzers, glucose analyzers, lactate analyzers, rapid and sepsis testing kits, reagents, and biomarkers. These products find application in blood banks, general surgeries, pharmacies, hospitals, diabetes clinics, laboratories, and sports medicine. It offers these products throughout the world through subsidiaries, and distributors. The company operates manufacturing facilities in Russia, Poland, Germany, the UK, Ireland, and the US. EKF Diagnostics is headquartered in Cardiff, Wales, the UK.

EKF Diagnostics Holdings Plc (EKF)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

EKF Diagnostics Holdings Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

EKF Diagnostics Holdings Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

EKF Diagnostics Holdings Plc, Medical Equipment, Deal Details 12

Venture Financing 12

Selah Genomics Raises USD0.4 Million in Financing Round 12

Private Equity 12

Selah Genomics Acquires Lab21, Maker Of Nanotechnology-Enabled Products 12

Partnerships 13

EKF Diagnostics Enters Into Licensing Agreement With Joslin Diabetes Center 13

Arcis Biotech Enters Into Licensing Agreement With EKF Diagnostics 14

Selah Genomics, Greenville Health, DecisionQ and Becton Dickinson Enter into Agreement 15

EKF Diagnostics Enters into Co-Development Agreement with Angle 15

EKF Diagnostics Enters into Research Agreement with Massachusetts General Hospital 16

EKF Diagnostics Enters Into Distribution Agreement With Alere 17

Selah Genomics Enters Into Licensing Agreement With UNIConnect For UniFlow 18

Equity Offering 18

EKF Diagnostics Raises USD7 Million in Private Placement of Shares 18

International Brand Completes Private Placement Of Shares For US$21 Million 20

Asset Transactions 20

EKF Diagnostics Plans to Divest POC Dx Business for USD110 Million 20

Acquisition 21

EKF Diagnostics to Sell Selah Genomics 21

Jin Jing to Acquire EKF Diagnostics 22

EKF Diagnostics Completes Acquisition Of Selah Genomics For US$75 Million 23

EKF Diagnostics To Acquire DiaSpect Medical For US$34.4 Million 24

EKF Diagnostics Acquires Separation Technology, Manufacturer Of In-Vitro Diagnostics Devices, From Thermo Fisher Scientific For US$4 Million 25

EKF Diagnostics Acquires 360 Genomics, Cancer Diagnostics Company, For Up To US$14.4 Million 26

Selah Genomics Acquires EnGenCore, DNA Sequencing Company 27

EKF Diagnostics Acquires 3.62% Stake In Arcis Biotech For US$0.4 Million 28

EKF Diagnostics Sells International Brand Licensing For US$0.08 Million 28

EKF Diagnostics Completes Acquisition of Stanbio Lab 29

EKF Diagnostics Holdings Plc-Key Competitors 31

Key Employees 32

Locations And Subsidiaries 33

Head Office 33

Other Locations & Subsidiaries 33

Recent Developments 35

Financial Announcements 35

Mar 20, 2017: EKF Diagnostics Holdings: Final results 35

Sep 12, 2016: EKF Diagnostics Holdings: Half-year Report 36

Apr 12, 2016: EKF Diagnostics Holdings: Final results 39

Corporate Communications 45

Jul 11, 2016: EKF Diagnostics Holdings Appoints Carl Dominic Contadini As Non-Executive Director 45

May 09, 2016: EKF Diagnostics Announces Directorate Change 46

Apr 20, 2016: EKF Diagnostics Holdings Announces Directorate Change 47

Apr 08, 2016: EKF Diagnostics Holdings Announces Directorate Change 48

Product News 49

Jan 20, 2016: EKF Diagnostics highlight new clinical chemistry analyzer at Arab Health 2016 49

Appendix 50

Methodology 50

About GlobalData 50

Contact Us 50

Disclaimer 50

List of Figures

EKF Diagnostics Holdings Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

EKF Diagnostics Holdings Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

EKF Diagnostics Holdings Plc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

List of Tables

EKF Diagnostics Holdings Plc, Medical Equipment, Key Facts, 2016 1

EKF Diagnostics Holdings Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

EKF Diagnostics Holdings Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

EKF Diagnostics Holdings Plc, Deals By Market, 2011 to YTD 2017 9

EKF Diagnostics Holdings Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Selah Genomics Raises USD0.4 Million in Financing Round 12

Selah Genomics Acquires Lab21, Maker Of Nanotechnology-Enabled Products 12

EKF Diagnostics Enters Into Licensing Agreement With Joslin Diabetes Center 13

Arcis Biotech Enters Into Licensing Agreement With EKF Diagnostics 14

Selah Genomics, Greenville Health, DecisionQ and Becton Dickinson Enter into Agreement 15

EKF Diagnostics Enters into Co-Development Agreement with Angle 15

EKF Diagnostics Enters into Research Agreement with Massachusetts General Hospital 16

EKF Diagnostics Enters Into Distribution Agreement With Alere 17

Selah Genomics Enters Into Licensing Agreement With UNIConnect For UniFlow 18

EKF Diagnostics Raises USD7 Million in Private Placement of Shares 18

International Brand Completes Private Placement Of Shares For US$21 Million 20

EKF Diagnostics Plans to Divest POC Dx Business for USD110 Million 20

EKF Diagnostics to Sell Selah Genomics 21

Jin Jing to Acquire EKF Diagnostics 22

EKF Diagnostics Completes Acquisition Of Selah Genomics For US$75 Million 23

EKF Diagnostics To Acquire DiaSpect Medical For US$34.4 Million 24

EKF Diagnostics Acquires Separation Technology, Manufacturer Of In-Vitro Diagnostics Devices, From Thermo Fisher Scientific For US$4 Million 25

EKF Diagnostics Acquires 360 Genomics, Cancer Diagnostics Company, For Up To US$14.4 Million 26

Selah Genomics Acquires EnGenCore, DNA Sequencing Company 27

EKF Diagnostics Acquires 3.62% Stake In Arcis Biotech For US$0.4 Million 28

EKF Diagnostics Sells International Brand Licensing For US$0.08 Million 28

EKF Diagnostics Completes Acquisition of Stanbio Lab 29

EKF Diagnostics Holdings Plc, Key Competitors 31

EKF Diagnostics Holdings Plc, Key Employees 32

EKF Diagnostics Holdings Plc, Other Locations 33

EKF Diagnostics Holdings Plc, Subsidiaries 33

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

EKF Diagnostics Holdings Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16143
Site License
USD 500 INR 32285
Corporate User License
USD 750 INR 48428

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com